Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C35H39N5O5 |
Molecular Weight | 609.7147 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCCN1C(=O)[C@H](CC3=CC=CC=C3)N4C(=O)[C@](NC(=O)[C@H]5CN(C)[C@]6([H])CC7=CNC8=CC=CC(=C78)C6=C5)(O[C@@]24O)C(C)C
InChI
InChIKey=HEFIYUQVAZFDEE-MKTPKCENSA-N
InChI=1S/C35H39N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,16,18,20,23,27-29,36,44H,8,13-15,17,19H2,1-3H3,(H,37,41)/t23-,27-,28+,29+,34-,35+/m1/s1
Molecular Formula | C35H39N5O5 |
Molecular Weight | 609.7147 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://books.google.ru/books?id=MI544i8UdzUC&printsec=frontcover&hl=ru#v=onepage&q&f=falseCurator's Comment: Description was created based on several sources, including https://www.deadiversion.usdoj.gov/fed_regs/rules/2011/fr0331.htm | https://www.ncbi.nlm.nih.gov/pubmed/2822556 | https://www.ncbi.nlm.nih.gov/pubmed/10438027 | https://www.ncbi.nlm.nih.gov/pubmed/2809599
Sources: https://books.google.ru/books?id=MI544i8UdzUC&printsec=frontcover&hl=ru#v=onepage&q&f=false
Curator's Comment: Description was created based on several sources, including https://www.deadiversion.usdoj.gov/fed_regs/rules/2011/fr0331.htm | https://www.ncbi.nlm.nih.gov/pubmed/2822556 | https://www.ncbi.nlm.nih.gov/pubmed/10438027 | https://www.ncbi.nlm.nih.gov/pubmed/2809599
Ergocristine is an alkoloid originally isolated from Iberian ergot. In the rat, ergocristine acts as an alpha 2-adrenoceptors agonist, and an alpha 1-adrenoceptors antagonist. It is able to regulate glutamate uptake and dopamine release. Ergocristine is controlled as a list I chemical of because it is considered as a chemical precursor used in the illicit manufacture of lysergic acid diethylamide,
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/127559 | https://www.ncbi.nlm.nih.gov/pubmed/6688378
Curator's Comment: Ergocristine induces rotational behaviour in rats. No human data available.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0014046 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10438027 |
|||
Target ID: GO:0051935 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2809599 |
|||
Target ID: CHEMBL2093864 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2822556 |
|||
Target ID: CHEMBL1907610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2822556 |
|||
Target ID: CHEMBL4302 |
13.33 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with alpha-chymotrypsin-induced ocular hypertension. | 2002 Apr |
|
Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry. | 2004 Nov |
|
Mass spectral characterization of ergot alkaloids by electrospray ionization, hydrogen/deuterium exchange, and multiple stage mass spectrometry: Usefulness of precursor ion scan experiments. | 2006 |
|
Ergot alkaloids in Norwegian wild grasses: a mass spectrometric approach. | 2007 |
|
A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits. | 2007 Oct |
|
Liquid chromatography-tandem mass spectrometry characterization of ergocristam degradation products. | 2008 Oct 1 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/42476
The elevated prolactin concentration in rats declined immediately after a single bolus injection of ergocristine (30 ug/kg).
Route of Administration:
Parenteral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:09:20 GMT 2023
by
admin
on
Sat Dec 16 10:09:20 GMT 2023
|
Record UNII |
3E58HO2T0U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
8612
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
31116
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
93743
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
m4976
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000128588
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
SUB35832
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
208-120-7
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
Ergocristine
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
3E58HO2T0U
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
DTXSID40891858
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
511-08-0
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY | |||
|
4821
Created by
admin on Sat Dec 16 10:09:20 GMT 2023 , Edited by admin on Sat Dec 16 10:09:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT->PRECURSOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
|